Prevail Therapeutics Announces Appointment of William H. Carson, M.D., to Board of Directors
NEW YORK, Sept. 10, 2020 (GLOBE NEWSWIRE) — Prevail Therapeutics Inc. (Nasdaq: PRVL), a biotechnology company developing potentially disease-modifying AAV-based gene […]